Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow stem cells for Duchenne Muscular Dystrophy
NCT03067831Phase 2Unknown
- Sponsor
- Stem Cells Arabia
- Start
- Sep 2015
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived stem cells in Duchenne muscular dystrophy (DMD), sponsored by Stem Cells Arabia. Status: unknown.
02
Drugs
autologous bone marrow-derived stem cells
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT03067831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067831.